News/MT Newswires/Summit Therapeutics Trial of Ridinilazole Misses Primary Endpoint…Summit Therapeutics Trial of Ridinilazole Misses Primary Endpoint; Shares Tumble in Premarket TradingDec 20, 202114:27 UTCSMMT